Press Release August 09, 2019

Pfizer’s Upjohn to Merge with Mylan (Chemistry World)

In an article on the merger of Pfizer off-patent medicines unit Upjohn with generic pharmaceutical company Mylan, counsel Josh Whitehill comments on the outcomes of a large branded drug company selling its off-patent assets.

Read the article here.